Dergiler / Southern Clinics of Istanbul Eurasia / 2021 / Cilt: 32 - Sayı: 4

The Assessment of Insulin Resistance and Triglyceride/Glucose Index in Nonalcoholic Fatty Liver Disease

Sayfa
381–387
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In our study, it was also observed that the TgG index increased the risk of NAFLD, independent of HOMA-IR

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Insulin resistance is one of the most important risk factors for nonalcohol- ic fatty liver disease (NAFLD).
📊
Temel Bulgular & Veri:Methods: 986 patients who applied to University of Health Sciences Haseki Training and Research Hospital Internal Medicine Clinic between 2017–2018 and underwent an abdom- inal ultrasonography scan for any reason were included in the study retrospectively.
💡
Sonuç & Katkı:In our study, it was also observed that the TgG index increased the risk of NAFLD, independent of HOMA-IR
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2017–2018 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Insulin resistance is one of the most important risk factors for nonalcohol- ic fatty liver disease (NAFLD). Homeostasis Model Assessment-Insulin Resistance (HO- MA-IR) is a marker used to show insulin resistance. Triglyceride/Glucose index (TgG index) is a parameter that can be used to predict NAFLD and is as important as HOMA-IR. In this study, we aimed to determine the value of the HOMA-IR score and TgG index in predicting NAFLD. Methods: 986 patients who applied to University of Health Sciences Haseki Training and Research Hospital Internal Medicine Clinic between 2017–2018 and underwent an abdom- inal ultrasonography scan for any reason were included in the study retrospectively. All medical cases here were investigated in terms of all clinic and laboratory aspects in order to exclude other possible liver-related diseases before they were diagnosed with NAFLD. The patients were categorized and grouped in two different ways. The first is the group with or without NAFLD; the second group was categorized as the control group, prediabetic group and type 2 diabetic group. Results: Our study was conducted with a total of 986 patients, including 470 patients with NAFLD and 516 patients without NAFLD. When the TgG index is calculated; a statistically significant increase was observed in the incidence of NAFLD at levels above 8.4 (p<0.001). The correlation analysis revealed a positive correlation between the TgG index and HO- MA-IR (r=0.438). TgG index (p<0.001 OR=3.702), HOMA-IR (p=0.003, OR=1.143), ALT elevation (p=0.001, OR=1.020) were found to be the most effective risk factors when the Backward Stepwise method was used. Conclusion: The TgG index was found to be a remarkable predictor-parameter for NAFLD. While HOMA-IR increases the risk of NAFLD by 1.1 times, the the TgG index increases it 3.7 times. In our study, it was also observed that the TgG index increased the risk of NAFLD, independent of HOMA-IR

🔖

Bu Makaleye Atıf Yap

ÇELİK, M., AHBAB, S., HOCA, E., ATAOGLU, H. E. (2021). The Assessment of Insulin Resistance and Triglyceride/Glucose Index in Nonalcoholic Fatty Liver Disease. Southern Clinics of Istanbul Eurasia, Cilt: 32 - Sayı: 4, 381–387. https://ajindex.com/articles/418208

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obe- sity: biochemical, metabolic and clinical presentations. World J Gas- troenterol 2014;20:9330–7
  2. Turkish Diabetes Association. Insulin Resistance Workshop Report; 2017. p. 10–21
  3. Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, Fernán- dez-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes predic- tion in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Prev Med 2016;86:99–105
  4. Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Trip- olino C, et al. Markers of insulin resistance and carotid atherosclero- sis. A comparison of the homeostasis model assessment and triglycer- ide glucose index. Int J Clin Pract 2013;67:665–72
  5. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mech- anism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345–53
  6. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Fiorello S, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005;90:1578–82
  7. Utzschneider KM, Kahn SE. Review: The role of insulin resis- tance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006;91:4753–61
  8. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, et al. Diagnosing insulin resistance in the general popula- tion. Diabetes Care 2001;24:460–4
  9. Guerrero-Romero F, Villalobos-Molina R, Jiménez-Flores JR, Si- mental-Mendia LE, Méndez-Cruz R, Murguía-Romero M, et al. Fasting triglycerides and glucose index as a diagnostic test for insulin resistance in young adults. Arch Med Res 2016;47:382–7
  10. Zheng R, Du Z, Wang M, Mao Y, Mao W. A longitudinal epidemi- ological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease. Lipids Health Dis 2018;17:262
  11. Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Met- abolic clustering of risk factors: evaluation of Triglyceride-glucose in- dex (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr 2018;10:74
  12. Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS One 2019;14:e0212963
  13. Simental-Mendía LE, Rodríguez-Mo